Abstract
1 The effects of two assay methods, HPLC and EIA, on theophylline plasma levels (n = 254) and pharmacokinetics (n = 6) were examined on blood samples obtained from asthmatic patients and normal adult male volunteers. 2 The standard curves obtained and the plasma level values during plasma level monitoring of theophylline measured with two methods are well correlated each other within concentration range of 2.5 to 20.0 microgram/ml (P less than 0.001). EIA, however in general, appears to give a lower value than HPLC. 3 The values of plasma theophylline half-life and clearance analyzed using a two-compartment open system model were found different between the two assay methods and dissimilar to those previously reported by using ultraviolet method. 4 The sampling end-point and/or assay sensitivity particularly to measure a lower level of theophylline (less than 2.5 microgram/ml) can influence the pharmacokinetics for a potent bronchodilator with a narrow therapeutic margin, theophylline.
References
Oct 16, 1976·Lancet·R S GalenP A Brown
Jun 1, 1975·Annals of Internal Medicine·C W ZwillichM M Weinberger
Jul 1, 1978·Clinical Pharmacokinetics·R I Ogilvie
Jul 1, 1978·Clinical Pharmacokinetics·L HendelesG Johnson
Jul 11, 1977·JAMA : the Journal of the American Medical Association·T R KordashJ T McCall
Nov 1, 1976·The Journal of Pediatrics·G GiacoiaJ R Koup
Jun 1, 1977·The Journal of Allergy and Clinical Immunology·P LeungT D Bell
Aug 1, 1977·The Journal of Pediatrics·P D WalsonL M Taussig
Aug 1, 1977·Clinical Pharmacology and Therapeutics·F A ChrzanowskiE T Sugita
May 3, 1976·JAMA : the Journal of the American Medical Association·M H JacobsG Kessler
May 10, 1976·JAMA : the Journal of the American Medical Association·M W WeinbergerT L Petty
Dec 1, 1976·Clinical Pharmacology and Therapeutics·A KappasA P Alvares
May 1, 1975·The Journal of Pediatrics·G Levy, R Koysooko
May 1, 1976·The Journal of Pediatrics·P M LoughnanA H Neims
Apr 1, 1974·Journal of Pharmacokinetics and Biopharmaceutics·R K NayakN H Reavey-Cantwell
Jul 1, 1973·Clinical Pharmacology and Therapeutics·P A Mitenko, R I Ogilvie
Sep 20, 1973·The New England Journal of Medicine·P A Mitenko, R I Ogilvie
Jul 18, 1974·The New England Journal of Medicine·M Weinberger, S Riegelman
May 1, 1972·Clinical Pharmacology and Therapeutics·P A Mitenko, R I Ogilvie
May 1, 1972·Clinical Pharmacology and Therapeutics·J W JenneF M MacDonald
Apr 1, 1971·Journal of Pharmaceutical Sciences·M Gibaldi, H Weintraub
Citations
Jan 1, 1982·European Journal of Clinical Pharmacology·Y HoraiJ Kabe
Jan 1, 1983·European Journal of Clinical Pharmacology·Y HoraiA Ohnishi
May 7, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mariko MorishitaNicholas A Peppas
Feb 1, 1996·Therapeutic Drug Monitoring·Y TsunekawaT Nabeshima
Jan 1, 1988·The Journal of International Medical Research·D Bernocchi, C L Castiglioni
May 13, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Muhammad Fawad RasoolFaleh Alqahtani
Nov 1, 1987·The Journal of International Medical Research·S GiosueP Mancini
Oct 1, 1981·Journal of Pharmacokinetics and Biopharmaceutics·P ChennavasinD C Brater
Aug 13, 1982·Journal of Chromatography·K T MuirS Riegelman